Search tips
Search criteria 


Logo of brheartjLink to Publisher's site
Br Heart J. 1995 December; 74(6): 656–659.
PMCID: PMC484124

Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid.


OBJECTIVE--To study the effect of induced carnitine depletion on myocardial structure and function. SUBJECTS AND DESIGN--7 healthy adult volunteers given 1200 mg pivmecillinam per day for 7-8 weeks were studied by echocardiography before and after 7-8 weeks of treatment and a 15 months follow up after the treatment period. SETTING--Teaching hospital. MAIN OUTCOME MEASURES--Carnitine concentration in serum, urine, and muscle and echocardiographic measurements. RESULTS--After 7-8 weeks of treatment the median free serum carnitine concentration was reduced to 7% and the median total muscle carnitine concentration to 46% of the pretreatment levels. The median diastolic interventricular septum thickness decreased by 14% (mean 26%, P = 0.028) and the median left ventricular mass by 10% (mean 20%, P = 0.018). Fifteen months later these dimensions had increased but not completely returned to pretreatment values. CONCLUSIONS--Extended treatment with pivalic acid containing antibiotics causes carnitine depletion which may lead to changes in cardiac structure.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (756K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bremer J. Carnitine--metabolism and functions. Physiol Rev. 1983 Oct;63(4):1420–1480. [PubMed]
  • Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. J Clin Invest. 1984 Mar;73(3):857–867. [PMC free article] [PubMed]
  • Lombard KA, Olson AL, Nelson SE, Rebouche CJ. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am J Clin Nutr. 1989 Aug;50(2):301–306. [PubMed]
  • Holme E, Jodal U, Linstedt S, Nordin I. Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children. Scand J Clin Lab Invest. 1992 Sep;52(5):361–372. [PubMed]
  • Melegh B, Kerner J, Bieber LL. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol. 1987 Oct 15;36(20):3405–3409. [PubMed]
  • Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, Jodal U. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989 Aug 26;2(8661):469–473. [PubMed]
  • Bianchi PB, Davis AT. Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats. J Nutr. 1991 Dec;121(12):2029–2036. [PubMed]
  • Diep QN, Bøhmer T, Schjerven L. Reduced carnitine and ketogenesis in the pivampicillin treated rat. Biochem Pharmacol. 1992 Sep 25;44(6):1226–1228. [PubMed]
  • Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta. 1972 Mar;37:235–243. [PubMed]
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072–1083. [PubMed]
  • Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976 Jan;37(1):7–11. [PubMed]
  • Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977 Apr;55(4):613–618. [PubMed]
  • Eriksson BO, Lindstedt S, Nordin I. Hereditary defect in carnitine membrane transport is expressed in skin fibroblasts. Eur J Pediatr. 1988 Aug;147(6):662–663. [PubMed]
  • Eriksson BO, Gustafson B, Lindstedt S, Nordin I. Transport of carnitine into cells in hereditary carnitine deficiency. J Inherit Metab Dis. 1989;12(2):108–111. [PubMed]
  • Tein I, De Vivo DC, Bierman F, Pulver P, De Meirleir LJ, Cvitanovic-Sojat L, Pagon RA, Bertini E, Dionisi-Vici C, Servidei S, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res. 1990 Sep;28(3):247–255. [PubMed]
  • Garavaglia B, Uziel G, Dworzak F, Carrara F, DiDonato S. Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation. Neurology. 1991 Oct;41(10):1691–1693. [PubMed]
  • Hagenfeldt L, von Döbeln U, Holme E, Alm J, Brandberg G, Enocksson E, Lindeberg L. 3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis. J Pediatr. 1990 Mar;116(3):387–392. [PubMed]
  • Venizelos N, Ijlst L, Wanders RJ, Hagenfeldt L. beta-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res. 1994 Jul;36(1 Pt 1):111–114. [PubMed]
  • Wanders RJ, IJlst L, Poggi F, Bonnefont JP, Munnich A, Brivet M, Rabier D, Saudubray JM. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun. 1992 Nov 16;188(3):1139–1145. [PubMed]
  • Diep QN, Bøhmer T, Skrede S. Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat. Biochim Biophys Acta. 1995 Jan 18;1243(1):65–70. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group